Eudaemon Technologies is a Sydney-based clinical-stage medtech developing next-generation hydrogel barrier technology, led by the world's first hydrogel condom - a latex-free, 50-percent-water material designed to replicate the mechanical and thermal properties of human tissue. Growing out of research backed by the Bill & Melinda Gates Foundation's Grand Challenges initiative, the company manufactures at its own advanced facility in Annandale, holds patents granted in the US and China, and is preparing pivotal clinical trials and regulatory clearances ahead of a targeted 2028 commercial launch in Australia and the United States.
1
Round
1
Industry
4
Tags
Oct 14, 2026
Latest raise
Funding activity · 1 round
Oct 14, 2026
AUD 4.5M
Seed
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
